Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. (endo,syn)-(+-)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane
2. Atrovent
3. Ipratropium
4. Ipratropium Bromide Anhydrous
5. Ipratropium Bromide Monohydrate
6. Ipratropium Bromide, (endo,anti)-isomer
7. Ipratropium Bromide, (exo,syn)-isomer
8. Ipratropium Bromide, Endo-isomer
9. Itrop
10. N Isopropylatropine
11. N-isopropylatropine
12. Sch 1000
13. Sch 1178
14. Sch-1000
15. Sch-1178
16. Sch1000
17. Sch1178
1. 22254-24-6
2. Atrovent
3. Itrop
4. Ipratropiumbromid
5. Bromure D'ipratropium
6. Bromuro De Ipratropio
7. Sch 1000
8. 8-isopropylnoratropine Methobromide
9. Ipratropium Bromide [inn]
10. Ipratropium Bromide'
11. Ipratropii Bromidum
12. N-isopropylnoratropinium Bromomethylate
13. Ipratropium Bromide Anhydrous
14. Vjv4x1p2z1
15. Mls000069557
16. 60251-88-9
17. Ipratropiumbromide
18. Smr000058764
19. (1r,5s)-3-((3-hydroxy-2-phenylpropanoyl)oxy)-8-isopropyl-8-methyl-8-azabicyclo[3.2.1]octan-8-ium Bromide
20. 24358-20-1
21. Ipratropium Bromide Monohydrate
22. 8-azoniabicyclo[3.2.1]octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, Bromide (1:1), (3-exo,8-syn)-
23. Rel-(1r,3r,5s,8r)-3-((3-hydroxy-2-phenylpropanoyl)oxy)-8-isopropyl-8-methyl-8-azabicyclo[3.2.1]octan-8-ium Bromide
24. Atem
25. 66985-17-9
26. Ipratropiumbromid [german]
27. Unii-vjv4x1p2z1
28. Ipratropii Bromidum [inn-latin]
29. Prestwick_279
30. Bromure D'ipratropium [inn-french]
31. Einecs 244-873-8
32. Einecs 261-098-0
33. Einecs 262-128-5
34. Bromuro De Ipratropio [inn-spanish]
35. Opera_id_1621
36. Schembl3852
37. Schembl3854
38. Schembl107906
39. (1s,3s,5r)-3-tropyloxy-8-isopropyltropanium Bromide
40. Ipratropium Bromide (anhydrous)
41. Chembl1464005
42. Ipratropium Bromide [mi]
43. Regid_for_cid_657308
44. Schembl16762661
45. Chebi:46659
46. Dtxsid10860753
47. Dtxsid60858923
48. Hms2234j05
49. Einecs 246-197-9
50. Bdbm50021892
51. Ipratropium Bromide [who-dd]
52. Mfcd00069291
53. Akos015895324
54. Akos030485952
55. (8r)-3-alpha-hydroxy-8-isopropyl-1-alpha-h,5-alpha-h-tropiumbromide-(+-)-tropate
56. 3-alpha-hydroxy-8-isopropyl-1-alpha-h,5-alpha-h-tropanium Bromide (+-)-tropate
57. (endo,anti)-(1)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo(3.2.1)octane Bromide
58. (exo,syn)-(1)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo(3.2.1)octane Bromide
59. Bi164579
60. N-isopropylnortropine Tropate Methobromide
61. C74140
62. T72808
63. Q424294
64. 3alpha-hydroxy-8-isopropyl-1alphah,5alphah-tropanium Bromide (+-)-tropate
65. 1-alpha-h,5-alpha-h-tropanium, 3-alpha-hydroxy-8-isopropyl-, Bromide, (+-)-tropate
66. (1r,3r,5s)-3-(3-hydroxy-2-phenylpropanoyloxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane Bromide
67. (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane Bromide
68. (endo,syn)-(+-)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane Bromide
69. 8-azoniabicyclo(3.2.1)octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, Bromide, Endo-
70. Endo-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo(3.2.1)octane Bromide
71. Rel-(1r,3r,5s,8s)-3-((3-hydroxy-2-phenylpropanoyl)oxy)-8-isopropyl-8-methyl-8-azabicyclo[3.2.1]octan-8-ium Bromide
Molecular Weight | 412.4 g/mol |
---|---|
Molecular Formula | C20H30BrNO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 411.14091 g/mol |
Monoisotopic Mass | 411.14091 g/mol |
Topological Polar Surface Area | 46.5 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 430 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Atrovent |
PubMed Health | Ipratropium (Into the nose) |
Drug Classes | Nasal Agent |
Drug Label | The active ingredient in ATROVENT Nasal Spray is ipratropium bromide (as the monohydrate). It is an anticholinergic agent chemically described as 8-azoniabicyclo[3.2.1]octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, bromide m... |
Active Ingredient | Ipratropium bromide |
Dosage Form | Spray, metered |
Route | Nasal |
Strength | 0.042mg/spray; 0.021mg/spray |
Market Status | Prescription |
Company | Boehringer Ingelheim |
2 of 4 | |
---|---|
Drug Name | Ipratropium bromide |
PubMed Health | Ipratropium |
Drug Classes | Bronchodilator, Nasal Agent |
Drug Label | The active ingredient in Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is ipratropium bromide monohydrate. It is an anticholinergic agent chemically described as 8-azoniabicyclo [3.2.1] octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-... |
Active Ingredient | Ipratropium bromide |
Dosage Form | Spray, metered; Solution |
Route | Nasal; Inhalation |
Strength | 0.042mg/spray; 0.02%; 0.021mg/spray |
Market Status | Prescription |
Company | Ritedose; Nephron; Mylan Speclt; Roxane; Watson Labs; Bausch And Lomb; Landela Pharm |
3 of 4 | |
---|---|
Drug Name | Atrovent |
PubMed Health | Ipratropium (Into the nose) |
Drug Classes | Nasal Agent |
Drug Label | The active ingredient in ATROVENT Nasal Spray is ipratropium bromide (as the monohydrate). It is an anticholinergic agent chemically described as 8-azoniabicyclo[3.2.1]octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, bromide m... |
Active Ingredient | Ipratropium bromide |
Dosage Form | Spray, metered |
Route | Nasal |
Strength | 0.042mg/spray; 0.021mg/spray |
Market Status | Prescription |
Company | Boehringer Ingelheim |
4 of 4 | |
---|---|
Drug Name | Ipratropium bromide |
PubMed Health | Ipratropium |
Drug Classes | Bronchodilator, Nasal Agent |
Drug Label | The active ingredient in Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is ipratropium bromide monohydrate. It is an anticholinergic agent chemically described as 8-azoniabicyclo [3.2.1] octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-... |
Active Ingredient | Ipratropium bromide |
Dosage Form | Spray, metered; Solution |
Route | Nasal; Inhalation |
Strength | 0.042mg/spray; 0.02%; 0.021mg/spray |
Market Status | Prescription |
Company | Ritedose; Nephron; Mylan Speclt; Roxane; Watson Labs; Bausch And Lomb; Landela Pharm |
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Cholinergic Antagonists
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)
R03BB01
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
R - Respiratory system
R01 - Nasal preparations
R01A - Decongestants and other nasal preparations for topical use
R01AX - Other nasal preparations
R01AX03 - Ipratropium bromide
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03B - Other drugs for obstructive airway diseases, inhalants
R03BB - Anticholinergics
R03BB01 - Ipratropium bromide
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
Certificate Number : CEP 2023-137 - Rev 00
Issue Date : 2024-11-05
Type : Chemical
Substance Number : 919
Status : Valid
Date of Issue : 2022-06-13
Valid Till : 2025-07-02
Written Confirmation Number : WC-0155
Address of the Firm :
NDC Package Code : 66412-0753
Start Marketing Date : 2019-09-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21179
Submission : 2007-12-15
Status : Active
Type : II
Certificate Number : R1-CEP 2008-150 - Rev 03
Issue Date : 2022-10-14
Type : Chemical
Substance Number : 919
Status : Valid
Date of Issue : 2023-01-06
Valid Till : 2025-07-29
Written Confirmation Number : WC-0099
Address of the Firm :
NDC Package Code : 15308-1001
Start Marketing Date : 2002-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-01-15
Pay. Date : 2014-01-03
DMF Number : 15130
Submission : 2000-11-06
Status : Active
Type : II
Certificate Number : R1-CEP 2012-126 - Rev 02
Issue Date : 2023-04-14
Type : Chemical
Substance Number : 919
Status : Valid
Date of Issue : 2022-07-28
Valid Till : 2025-06-16
Written Confirmation Number : WC-0036
Address of the Firm :
NDC Package Code : 58032-0100
Start Marketing Date : 2015-04-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Registrant Name : Aging Life Science Co., Ltd.
Registration Date : 2020-07-02
Registration Number : 20130614-188-I-356-02(A)
Manufacturer Name : Neuland Laboratories Ltd.
Manufacturer Address : Unit-I, Sy. No: 347, 473, 474, 490/2, Bonthapally Village, Veerabhadraswamy Temple Road, Gummadidala Mandal, Sangareddy District - 502 313, Telangana State, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14259
Submission : 1999-06-25
Status : Active
Type : II
Certificate Number : R1-CEP 1996-005 - Rev 05
Issue Date : 2015-10-08
Type : Chemical
Substance Number : 919
Status : Valid
Registration Number : 220MF10081
Registrant's Address : Binger Strasse 173,55216 Ingelheim am Rhein
Initial Date of Registration : 2008-03-14
Latest Date of Registration : --
NDC Package Code : 12714-049
Start Marketing Date : 2011-05-09
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Boehringer Ingelheim Korea Ltd.
Registration Date : 2012-09-19
Registration Number : 20120919-188-I-64-01
Manufacturer Name : Boehringer Ingelheim Pharma GmbH & Co. K.G.
Manufacturer Address : Binger Strasse 173, 55216 Ingelheim am Rhein
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-02-17
Pay. Date : 2013-09-12
DMF Number : 8973
Submission : 1991-02-18
Status : Active
Type : II
Registrant Name : Hanlim Pharmaceutical Co., Ltd.
Registration Date : 2018-06-27
Registration Number : 20130806-188-I-301-03(2)
Manufacturer Name : Sifavitor Srl
Manufacturer Address : Casaletto Lodigiano (LO) - Via Livelli, 1 - Fraz. Mairano, Italy.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-03-16
Pay. Date : 2022-11-04
DMF Number : 31036
Submission : 2017-11-28
Status : Active
Type : II
NDC Package Code : 52221-108
Start Marketing Date : 2014-07-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-02-05
Pay. Date : 2015-01-27
DMF Number : 8979
Submission : 1991-02-15
Status : Active
Type : II
Certificate Number : R1-CEP 2004-220 - Rev 01
Issue Date : 2020-11-26
Type : Chemical
Substance Number : 919
Status : Valid
NDC Package Code : 43898-0102
Start Marketing Date : 1991-02-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Takeda Pharmaceutical Company Korea Ltd.
Registration Date : 2013-10-20
Registration Number : 20131020-188-I-346-04
Manufacturer Name : Lusochimica SpA
Manufacturer Address : Lomagna (LC) - Via Giotto 9, Italy
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23135
Submission : 2009-09-28
Status : Inactive
Type : II
NDC Package Code : 59349-0013
Start Marketing Date : 2018-11-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 710-11-2
End Use API : Ipratropium Bromide
About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domesti...
(9-isopropyl-9-azabicyclo[3,3,1] non-3-yl) methano...
CAS Number : 1209437-82-0
End Use API : Ipratropium Bromide
About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domesti...
N-Isopropyl Noratropine (IPT-II)
CAS Number : 3423-25-4
End Use API : Ipratropium Bromide
About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer. Specializing in anti-asthmatic, anti-migraine & anti-psychotic APIs, it caters to domesti...
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Reply
21 Apr 2023
Reply
10 Sep 2022
Reply
20 Nov 2020
Reply
23 Oct 2019
Reply
07 Sep 2019
Reply
22 Apr 2019
Reply
10 Apr 2019
Reply
16 Feb 2019
Reply
10 Oct 2018
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?